James J. Bochnowski, Director at Jaguar Health, Inc. (JAGX), bought 100,000 shares at $0.50 ($50K) on 2017-06-28, disclosed to the SEC on 2017-08-02.
Open-market purchase of $50k JAGX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| SENS | BUY | 2016-03-23 | $7.0M | — | Filing → |
| JAGX | BUY | 2016-02-09 | $400K | — | Filing → |
| CALA | BUY | 2014-10-09 | $5.0M | — | Filing → |